CCLA – Cancer Cell Line Authentication

CCLA

:: DESCRIPTION

CCLA is a web server to authenticate human cancer cell lines (CCLs) using expression profiles from RNA-Seq or microarray data.

::DEVELOPER

An-Yuan Guo’s Bioinformatics Laboratory

:: SCREENSHOTS

N/A

::REQUIREMENTS

  • Web Browser

:: DOWNLOAD

 NO

:: MORE INFORMATION

Citation

Zhang Q, Luo M, Liu CJ, Guo AY.
CCLA: an accurate method and web server for cancer cell line authentication using gene expression profiles.
Brief Bioinform. 2021 May 20;22(3):bbaa093. doi: 10.1093/bib/bbaa093. PMID: 32510568.

TCLP – Online Cancer Cell Line Catalogue integrating HLA type

TCLP

:: DESCRIPTION

TCLP (TRON CELL LINE PORTAL)is the largest catalog of cancer cell line annotations integrating HLA type, HLA expression, predicted HLA Class I and Class II neo-epitopes, virus, and gene expression.

::DEVELOPER

The Institute for Translational Oncology and Immunology(TrOn)

:: SCREENSHOTS

N/A

:: REQUIREMENTS

  • Web browser

:: DOWNLOAD

NO

:: MORE INFORMATION

Citation

Scholtalbers J, Boegel S, Bukur T, Byl M, Goerges S, Sorn P, Loewer M, Sahin U, Castle JC:
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.
Genome medicine 2015, 7:118.

DiPCell – Designing of Inhibitors against Pancreatic Cancer Cell Lines

DiPCell

:: DESCRIPTION

DiPCell is a webserver for the predicting inhibitory activity of unknown molecules and designing their analogs against pancreatic cancer cell lines. DiPCell implements the QSAR models, which were developed by using SMOreg machine learning algorithm on high throughput drug screening data. This high throughput screening data is obtained from the Genomics of Drug Sensitivity in Cancer (GDSC) database.

::DEVELOPER

DiPCell team

:: SCREENSHOTS

N/A

:: REQUIREMENTS

  • Web Browser

:: DOWNLOAD

 NO

:: MORE INFORMATION

Citation

Designing of promiscuous inhibitors against pancreatic cancer cell lines.
Kumar R, Chaudhary K, Singla D, Gautam A, Raghava GP.
Sci Rep. 2014 Apr 14;4:4668. doi: 10.1038/srep04668.

Exit mobile version